Description: Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. The company was founded in 2005 and is based in Beijing, China.
Home Page: www.hotgen.com.cn
Zhongguancun High-end Medical Device Ind
Beijing,
102629
China
Phone:
86 10 5097 3660
Officers
| Name | Title |
|---|---|
| Mr. Changqing Lin | Chairman & GM |
| Ms. Jing Li | Chairman of the Supervisory Board & Director of Customer Service |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 3.0071 |
| Price-to-Book MRQ: | 2.0675 |
| Price-to-Sales TTM: | 1.5834 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1019 |